FDA Authorized Zyn Pouches Without Knowing Ingredients

The FDA has granted authorization to Zyn nicotine pouches for market sale. This approval was granted despite regulators not knowing exactly what the pouches contain. A report highlights the lack of transparency regarding the product's full composition. Questions have been raised about potential risks such as microplastics in the product. The situation raises concerns about the regulatory process for tobacco products. Public health advocates may worry about unknown long-term health effects. The specific chemical makeup of the pouches remains unclear to the oversight body. Scrutiny on the approval process is likely to increase following this revelation.